|
Written by Administrator
|
|
AcureOmics cofounder Johan Trygg in best practice study of gene expression data Dr Johan Trygg, co-founder of AcureOmics AB, has participated in a large international project (MAQC-II) aimed to examine and generate "best practice" protocols in data analysis for predicting clinical endpoints based on gene expression data. |
|
Read more...
|
|
|
Written by Administrator
|
|
Renewed SME status for AcureOmics AcureOmics AB has renewed its' status as SME (micro, small and medium-sized enterprizes) with EMA (European Medicines Agency). - The SME status is important for AcureOmics AB and has proven to be key for establishing collaborations and gaining access to research networks in the European community, says Jon Gabrielsson, CEO AcureOmics AB. For further information from the SME Office click here |
|
|
Written by Administrator
|
|
AcureOmics AB granted millions by EU for metabolic disease project
Umeå based company AcureOmics AB, with unique knowledge on metabolomics, is taking part in BOLD (Biology of Liver and Pancreatic Development and Disease), a Marie Curie Initial Training Network (ITN) within EU’s FP7 program. The BOLD project aims to provide new knowledge on metabolic disease of the liver and pancreas. The 39 MSEK project is coordinated by the University of Birmingham and will run through 2013. AcureOmics will develop tools for routine assessment (“high throughput”) of disease symptoms found in the liver and pancreas, both in animal models and patients with disturbed metabolism. The aim is to develop new treatment for related diseases, based on increased knowledge on individual disturbances in metabolism and the regulation of genetic and metabolic factors will affect the functions. In this way links between individual genotype and metabolic profile can be found that will primarily increase the understanding of development of diabetes BOLD will also generate new tools to assess individuals’ response to treatment depending on genotype and “metabotype”. |
|
Read more...
|
|
|
Written by Administrator
|
|
AcureOmics cofounder Johan Trygg awarded Herman Wold gold medal Dr Johan Trygg is the youngest ever recipient of the Herman Wold medal in gold, awarded by Swedish Chemical Society to researchers whos contributions have been of great importance for the development of chemometrics. Since 1995 the prize has been exclusively awarded to seven legendary professors in the field. |
|
Read more...
|
|
|
Written by Administrator
|
AcureOmics founders speak at SSC11Professor Torbjörn Lundstedt and associate professor Johan Trygg, two of the founders of AcureOmics AB, are invited lecturers at the 11th Scandinavian Symposium on Chemometrics (SSC11). The SSC conferences are biannual and rotate amongst the Nordic countries, this year taking place in Loen/Stryn, Norway. Johan Trygg opened the conference with a presentation on the role of chemometrics in personalized medicine. In Torbjörn Lundstedts lecture he shared his experience on chemometric strategies for extracting holistic information. The conference is held between June 8-11, for more information click here. |
|
|
|
<< Start < Previous 1 2 Next > End >>
|
| Results 1 - 9 of 13 |
